Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |6 September 2005

Potential Benefits of Amiodarone for Patients Undergoing Open-Heart Surgery

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information

  • The summary below is from the full report titled “Amiodarone Prophylaxis Reduces Major Cardiovascular Morbidity and Length of Stay after Cardiac Surgery: A Meta-Analysis.” It is in the 6 September 2005 issue of Annals of Internal Medicine (volume 143, pages 327-336). The authors are J.D. Aasbo, A.T. Lawrence, K. Krishnan, M.H. Kim, and R.G. Trohman.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the researchers do this particular study?
    • Who was studied?
    • How was the study done?
    • What did the researchers find?
    • What were the limitations of the study?
    • What are the implications of the study?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the problem and what is known about it so far?

Irregular heart rates and rhythms (arrhythmias) occur commonly in the first week after heart surgery. They are associated with increased risks for stroke, heart attack, and death. They can increase postoperative care needs, length of hospital stay, and costs. Doctors usually give patients undergoing heart surgery beta-blocker drugs to help prevent dangerous heart rates and their complications. Another drug that they might consider giving is amiodarone. Amiodarone works by slowing down the electrical signals in both the upper chambers (atria) and lower chambers (ventricles) of the heart.

Why did the researchers do this particular study?

To see if giving amiodarone to adults undergoing heart surgery reduces length of hospital stay and risk for arrhythmias, stroke, heart attack, and death.

Who was studied?

1744 adults undergoing coronary bypass or heart valve surgery who participated in 10 trials of perioperative amiodarone therapy.

How was the study done?

The researchers searched the medical literature up to February 2005 to find randomized trials that compared amiodarone with dummy pills (placebo) in patients undergoing open-heart surgery. Patients could have received amiodarone just before, during, or immediately after surgery. The researchers then combined data about outcomes and side effects from the studies.

What did the researchers find?

Compared with placebo, amiodarone reduced the incidence of both atrial and ventricular arrhythmias. Amiodarone also reduced strokes and length of hospital stay. Its effects on heart attacks and deaths were unclear. Adverse effects of amiodarone included nausea and slow heart rate (bradycardia).

What were the limitations of the study?

Some trials were conducted in the early 1990s. Some participants did not get beta-blocker drugs, the currently recommended preventive treatment for patients undergoing heart surgery. Dosages and timing of amiodarone administration and follow-up duration varied across studies.

What are the implications of the study?

Perioperative amiodarone may benefit some patients undergoing heart surgery. We now need trials that compare amiodarone plus beta-blockers versus beta-blockers alone to see if the combination better prevents adverse outcomes than do beta-blockers alone.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Potential Benefits of Amiodarone for Patients Undergoing Open-Heart Surgery. Ann Intern Med. 2005;143:I–26. doi: https://doi.org/10.7326/0003-4819-143-5-200509060-00003

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2005;143(5):I-26.

DOI: 10.7326/0003-4819-143-5-200509060-00003

©
2005 American College of Physicians
0 Citations
Advertisement

See Also
Amiodarone Prophylaxis Reduces Major Cardiovascular Morbidity and Length of Stay after Cardiac Surgery: A Meta-Analysis
View MoreView Less

Related Articles
Review: In noncardiac surgery, amiodarone, β-blocker, or statin prophylaxis reduces postoperative AF
Annals of Internal Medicine; 169 (2): JC7
Metoprolol Versus Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Randomized Trial
Annals of Internal Medicine; 153 (11): 703-709
Review: Amiodarone reduces risk for sudden cardiac death but not all-cause mortality in cardiomyopathy
Annals of Internal Medicine; 151 (8): JC4-13
Defibrillator therapy improved quality of life in CHF; amiodarone did not
Annals of Internal Medicine; 150 (2): JC1-10
View MoreView Less

Journal Club
Review: In noncardiac surgery, amiodarone, β-blocker, or statin prophylaxis reduces postoperative AF
Annals of Internal Medicine; 169 (2): JC7
Review: Amiodarone reduces risk for sudden cardiac death but not all-cause mortality in cardiomyopathy
Annals of Internal Medicine; 151 (8): JC4-13
Defibrillator therapy improved quality of life in CHF; amiodarone did not
Annals of Internal Medicine; 150 (2): JC1-10
View MoreView Less

Related Topics
Cardiology
Rhythm Disorders and Devices

Cardiology, Rhythm Disorders and Devices.

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×